Medytox Venture Investment Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
56
- Portfolio
-
36
- Exits
-
8
Medytox Venture Investment General Information
Company Description
Founded in 2017, Medytox Venture Investment is a corporate venture capital arm of Medytox based in Seoul, South Korea. The firm seeks to invest in companies operating in the technology, healthcare, new drug development, medical device, diagnosis, cosmeceutical, food, and wellbeing sectors.
Business Details
Website
www.medytoxventure.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 10th Floor, 516, Teheran-ro
- Gangnam-gu, Seoul (Daechi-dong, Jeongheon Building)
- Seoul, Gangnam-gu
- South Korea
Medytox Venture Investment Investments (56)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| NEX-I | 04-Jun-2026 | Later Stage VC | Drug Discovery | Profitable | ||
| DigmBio | 25-Mar-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Inventera | 30-Oct-2024 | Drug Discovery | Generating Revenue | |||
| PINE Digital Health | 01-Aug-2024 | Therapeutic Devices | Product Development | |||
| biobricks | 01-Jun-2024 | Biotechnology | Generating Revenue | |||
| Avelos Therapeutics | 02-May-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Kanaph Therapeutics | 02-Jan-2024 | Drug Discovery | Generating Revenue | |||
| GPCR Therapeutics | 28-Nov-2023 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Zymedi | 30-May-2023 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Trioar Biotechnology | 23-May-2023 | Early Stage VC | Drug Discovery | Pre-Clinical Trials |
Medytox Venture Investment Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| NEX-I | 12-Nov-2026 | IPO | |
| Cellapeutics Bio | 14-Aug-2026 | ||
| Inventera | 02-Apr-2026 | ||
| Kanaph Therapeutics | 16-Mar-2026 | ||
| Welsmeditech | 03-Apr-2025 | ||
| EPD Biotherapeutics | 01-Oct-2024 | ||
| Endomics | 26-Apr-2024 | Out of Business | |
| Sensorview | 19-Jul-2023 | IPO |
Medytox Venture Investment Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Medytox Venture Investment Co-Investors (110)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| UTC Investment | 6 |
|
|
||
| Company K Partners |
|
|
|||
| Hana Ventures |
|
|
|||
| LSK Investment |
|
|
|||
| Atinum Investment |
|
|
Medytox Venture Investment FAQs
-
What is Medytox Venture Investment?
Founded in 2017, Medytox Venture Investment is a corporate venture capital arm of Medytox based in Seoul, South Korea.
-
When was Medytox Venture Investment founded?
Medytox Venture Investment was founded in 2017.
-
Where is Medytox Venture Investment headquartered?
Medytox Venture Investment is headquartered in Seoul, South Korea.
-
How many investments has Medytox Venture Investment made?
Medytox Venture Investment has made 56 investments.
-
What has Medytox Venture Investment invested in?
Medytox Venture Investment has made numerous investments in companies like NEX-I, DigmBio, and Inventera within the Drug Discovery industry.
-
What has Medytox Venture Investment invested in recently?
Medytox Venture Investment's latest investment was on 04-Jun-2026 in NEX-I, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
